The need for new treatments is not slowing down.
Several of the most debilitating conditions are expected to increase in the next decade. We work with private investors who wish to make a positive impact in the health and biomedical sectors. They care for more than only returns; they want to see their investments turn into life changing therapies.
We source directly from our network of innovation hubs and scientists across Europe and beyond in order to find the most promising novel treatments and share them with our investors. We are driven by the search for start-ups which, if successful, will have a serious impact on the health of patients across the globe.
We select very few companies through a solid data-driven due diligence process based on our own in-house scientific knowledge and on key opinion leaders from each specific field. Our analysis is grounded in hard facts and high-quality data as well as the early detection of talented entrepreneurs.